James V. Caruso, Chief Commercial Officer at ALLOS THERAPEUTICS INC (ALTH), sold 5,968 shares at $7.44 ($44K) on 2010-02-23, disclosed to the SEC on 2010-02-24.
Scheduled sale ($44k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |